Calliditas eyes 2022 approval in EU for rare kidney disease drug NefeconCalliditas Therapeutics is on course to launch its first product, Nefecon for rare disease primary IgA nephropathy (IgAN), Share XCalliditas eyes 2022 approval in EU for rare kidney disease drug Nefeconhttps://pharmaphorum.com/news/calliditas-eyes-2022-approval-in-eu-for-rare-kidney-disease-drug-nefecon/
EMA starts review of GSK/Vir COVID-19 antibodyThe EMA has started reviewing the emergency use application for GlaxoSmithKline and Vir Biotech’s COVID-19 antibody VIR-7831, which Share XEMA starts review of GSK/Vir COVID-19 antibodyhttps://pharmaphorum.com/news/ema-starts-review-of-gsk-vir-covid-19-antibody/
UK will offer under-30s alternative to AZ’s COVID jabThe UK drugs regulator has said people aged under 30 should be offered an alternative to the AstraZeneca Share XUK will offer under-30s alternative to AZ’s COVID jabhttps://pharmaphorum.com/news/uk-will-offer-under-30s-alternative-to-azs-covid-jab/
Paediatric trial of AZ COVID jab ‘halted as a precaution’Oxford University has suspended a clinical trial of its AstraZeneca-partnered COVID-19 vaccine in children and adolescents while a Share XPaediatric trial of AZ COVID jab ‘halted as a precaution’https://pharmaphorum.com/news/paediatric-trial-of-az-covid-jab-halted-as-a-precaution/
CHMP backs Celltrion’s regdanvimab antibody for COVID-19The EU looks set to approve emergency use of a third antibody therapy for COVID-19 after its human Share XCHMP backs Celltrion’s regdanvimab antibody for COVID-19https://pharmaphorum.com/news/chmp-backs-celltrions-regdanvimab-antibody-for-covid-19/
EMA review finds AZ COVID-19 vaccine “safe and effective”An EMA advisory committee’s review of AstraZeneca’s COVID-19 has concluded that there is no increase in the overall Share XEMA review finds AZ COVID-19 vaccine “safe and effective”https://pharmaphorum.com/news/ema-review-finds-az-covid-19-vaccine-safe-and-effective/
States halting AZ jab a ‘disaster’ for EU’s COVID vaccination programmeThe decision by around a dozen EU countries to suspend dosing with AstraZeneca’s COVID-19 vaccine is facing criticism, Share XStates halting AZ jab a ‘disaster’ for EU’s COVID vaccination programmehttps://pharmaphorum.com/news/states-halting-az-jab-a-disaster-for-eus-covid-vaccination-programme/
J&J’s COVID-19 shot backed for emergency use in EUThe EU’s medicines regulator has recommended granting conditional approval to a fourth COVID-19 vaccine – a single-dose shot Share XJ&J’s COVID-19 shot backed for emergency use in EUhttps://pharmaphorum.com/news/jjs-covid-19-shot-backed-for-emergency-use-in-eu/
EU regulators probe safety of AstraZeneca vaccine batch after blood clot reportsEuropean safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 Share XEU regulators probe safety of AstraZeneca vaccine batch after blood clot reportshttps://pharmaphorum.com/news/eu-regulators-probe-safety-of-az-vaccine-batch/
